On ECHEMI
Home > Drugs > Yohimbine hydrochloride Registered Holders
Yohimbine hydrochloride structure

Yohimbine hydrochloride structure

Yohimbine hydrochloride

Yohimbine hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine.IC50 value:Target:In vitro:In vivo: Yohimbine hydrochloride (0.2 mg/kg, i.p.) was administered to rats 1h before the stress session daily for 14 consecutive days and its effect was assessed. Results of this section revealed that, immersion of rats in cold water significantly decreased sexual arousal and

Find 3 Related Holders

BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG
United States United States

API Registration Country

API Inactive
SIGMA F AND D DIV LTD
United States United States

API Registration Country

API Inactive
VITAL LABORATORIES PVT LTD
United States United States

API Registration Country

API Inactive
Recommended Suppliers of Yohimbine hydrochloride
View 113 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.